Contact
Please use this form to send email to PR contact of this press release:
Choroideremia Research Foundation Acquires Spark Therapeutics, Inc., CHM Gene Therapy Assets, Advances Data Analysis
TO:
Reagan Devinney
Choroideremia Research Foundation Inc
+ +1 800-210-0233